TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomerieux Norge AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
71,862
|
64,180
|
72,496 |
| Financial expenses |
420
|
359
|
298 |
| Earnings before taxes |
3,695
|
5,275
|
6,493 |
| Total assets |
21,892
|
25,677
|
33,644 |
| Current assets |
17,385
|
23,642
|
33,041 |
| Current liabilities |
15,719
|
22,441
|
25,701 |
| Equity capital |
6,172
|
3,237
|
7,943 |
| - share capital |
2,667
|
2,715
|
2,907 |
| Employees (average) | 3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
28.2%
|
12.6%
|
23.6% |
| Turnover per employee | 21,393 | ||
| Profit as a percentage of turnover |
5.1%
|
8.2%
|
9.0% |
| Return on assets (ROA) |
18.8%
|
21.9%
|
20.2% |
| Current ratio |
110.6%
|
105.4%
|
128.6% |
| Return on equity (ROE) |
59.9%
|
163.0%
|
81.7% |
| Change turnover |
8,819
|
-3,513
|
-18,063 |
| Change turnover % |
14%
|
-5%
|
-20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.